Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2016-02-24 Director's Dealing
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Director's Dealing 2016
Director's Dealing Classification · 99% confidence The document explicitly reports a transaction involving shares by a former executive ('Jens Bager, Former President and CEO'). It details the transaction type ('Purchase'), the number of shares (5,000), the market value, and the trading date, citing compliance with the Danish Securities Trading Act. This structure perfectly matches the definition of a Director's Dealing report, which covers personal share transactions by directors and executives (insider trades).
2016-02-24 Danish
Director's Dealing 2016
Director's Dealing Classification · 100% confidence The document text is a formal notification, written in Danish, detailing a transaction involving shares of ALK-Abelló A/S. Key fields like 'Navn' (Name), 'Årsag' (Reason - mentioning former CEO and insider rules), 'Transaktion' (Transaction - 'Køb' meaning Buy), 'Handelsdato' (Trade Date), 'Antal, stk.' (Number of shares), and 'Kursværdi' (Value) clearly indicate a report of insider trading or director's dealing. This aligns directly with the definition for Director's Dealing (Code: DIRS). The document is short and contains the specific transaction details, not just an announcement of a report.
2016-02-24 English
Indberetning af ledelsens transaktioner med ALK-Abelló A/S’ B-aktier
Director's Dealing Classification · 100% confidence The document is a formal notification regarding a transaction in the company's own shares by a former executive (Jens Bager). It explicitly references 'Indberetning af ledelsens transaktioner' (Reporting of management transactions) and provides details such as the name, transaction type (purchase), date, and volume. This falls under the category of Director's Dealing (DIRS).
2016-02-24 English
Indberetning af ledelsens transaktioner med ALK-Abelló A/S’ B-aktier
Director's Dealing Classification · 100% confidence The document is a formal notification of a share transaction by a former executive (Jens Bager) of ALK-Abelló A/S. It explicitly references the Danish Securities Trading Act regarding reporting transactions by managerial staff. This fits the definition of a Director's Dealing (DIRS) report, which covers personal share transactions by company directors and executives.
2016-02-24 English
Board/Management Information 2016
Board/Management Information Classification · 99% confidence The document is titled "Selskabsmeddelelse nr. 10/2016" (Company Announcement no. 10/2016) and explicitly states that the CEO, Jens Bager, is resigning effective immediately ("fratræder sin stilling som adm. direktør (President & CEO) med virkning fra 22. februar 2016"). This content directly relates to a change in senior management. This aligns perfectly with the definition for Board/Management Information (MANG). The document is not a full annual report (10-K), an earnings release (ER), or a transcript (CT).
2016-02-22 English
Board/Management Information 2016
Board/Management Information Classification · 100% confidence The document explicitly announces the resignation of the President and CEO, Jens Bager, and details the interim leadership arrangement involving the Chairman of the Board, Steen Riisgaard. This content directly relates to changes in senior management personnel. According to the definitions, this corresponds to Board/Management Information (MANG). The document is short and contains an announcement about a future conference call, but the core subject is the management change, not the announcement of a report itself.
2016-02-22 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.